TPBG
EMN icon

Turning Point Benefit Group’s Eastman Chemical EMN Stock Holding History

Turning Point Benefit Group’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed -$319 – 313
2025
Q4 		$319 Hold
5
– – ﹤0.01% 705
2025
Q3 		$309 Buy
+5
New +$349 ﹤0.01% 574

Other funds holding EMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Turning Point Benefit Group's EMN Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Eastman Chemical (EMN) in Q1 2026, closing a stake of 5 shares — an estimated $319 sold.

Turning Point Benefit Group first reported a position in EMN in Q3 2025 and held it in 2 quarters. The position peaked at $319 in Q4 2025. 640 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Turning Point Benefit Group reported no remaining Eastman Chemical position as of Q1 2026 after selling out during the quarter.
  • Turning Point Benefit Group sold 5 Eastman Chemical shares in Q1 2026, an estimated $319.
  • Turning Point Benefit Group first reported a position in Eastman Chemical in Q3 2025 and held it in 2 quarters.
  • Turning Point Benefit Group's Eastman Chemical position peaked at $319 in Q4 2025.
  • 640 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.